Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: PPD DEVELOPMENT LP
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2024-07-15 to 2025-07-14
Current total value of award: $305772
Description: PHASE I RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY TO ASSESS SAFETY, TOLERABILITY, AND PHARMACOKINETICS